News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
256,002 Results
Type
Article (13694)
Company Profile (257)
Press Release (242051)
Section
Business (79112)
Career Advice (146)
Deals (13170)
Drug Delivery (28)
Drug Development (50110)
Employer Resources (31)
FDA (5623)
Job Trends (5105)
News (143505)
Policy (10016)
Tag
Academia (900)
Africa (145)
Alabama (26)
Allergies (30)
Alliances (21385)
Alzheimer's disease (676)
Antibody-drug conjugate (ADC) (30)
Approvals (5592)
Arizona (38)
Artificial intelligence (26)
Asia (16607)
Australia (2772)
Bankruptcy (96)
Best Places to Work (4321)
Biotechnology (214)
C2C Services and Suppliers (10704)
California (1077)
Canada (450)
Cancer (201)
Career advice (127)
CAR-T (32)
Cell therapy (82)
China (73)
Clinical research (38862)
Collaboration (70)
Colorado (33)
Compensation (27)
Connecticut (35)
COVID-19 (973)
Cystic fibrosis (58)
Data (118)
Diabetes (31)
Diagnostics (1150)
Earnings (28363)
Employer resources (29)
Europe (35567)
Events (45618)
Executive appointments (72)
FDA (5711)
Florida (105)
Funding (74)
Gene therapy (71)
GLP-1 (255)
Government (1049)
Healthcare (6497)
Hotbed/Location (184267)
Illinois (63)
Indiana (42)
Infectious disease (981)
Inflammatory bowel disease (75)
IPO (7126)
Job creations (859)
Job search strategy (123)
Kansas (51)
Layoffs (175)
Legal (1368)
Lung cancer (42)
Maryland (166)
Massachusetts (878)
Medical device (2538)
Medtech (2538)
Mergers & acquisitions (6030)
Metabolic disorders (114)
Michigan (34)
Minnesota (61)
Neuroscience (764)
New Jersey (285)
New York (345)
NextGen Class of 2024 (1974)
Non-profit (836)
North Carolina (316)
Northern California (484)
Obesity (68)
Ohio (58)
Opinion (85)
Parkinson's disease (26)
Patents (33)
Peanut (27)
Pennsylvania (249)
People (24639)
Pharmaceutical (41)
Phase I (13634)
Phase II (18069)
Phase III (11501)
Pipeline (64)
Postmarket research (844)
Preclinical (5752)
Press Release (30)
Rare diseases (92)
Real estate (1406)
Regulatory (7997)
Research institute (927)
South America (206)
Southern California (444)
Startups (1962)
Texas (91)
United States (4174)
Vaccines (118)
Washington State (143)
Weight loss (53)
Date
Today (6)
Last 7 days (346)
Last 30 days (1125)
Last 365 days (21414)
2024 (14404)
2023 (22412)
2022 (26986)
2021 (27808)
2020 (23358)
2019 (16224)
2018 (11760)
2017 (13780)
2016 (11854)
2015 (14352)
2014 (10392)
2013 (7484)
2012 (7540)
2011 (7627)
2010 (7445)
256,002 Results for "vbl therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Notable Labs Closes Merger Transaction With VBL Therapeutics
Notable Labs, Inc., a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, announced the completion of its merger transaction with VBL Therapeutics and associated financing.
October 16, 2023
·
9 min read
Pharm Country
VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting
VBL Therapeutics, announced that its shareholders voted to approve the previously announced proposed merger with Notable Labs, Inc., at the annual and special meeting which took place, October 12, 2023.
October 12, 2023
·
4 min read
Pharm Country
VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting
VBL Therapeutics, reminds its shareholders to vote in favor of the previously announced proposed merger with Notable Labs at the annual and special meeting for shareholders of record as of September 5, 2023.
October 4, 2023
·
9 min read
Business
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced financial results for the second quarter ended June 30, 2023, and provided a corporate update.
August 14, 2023
·
10 min read
Deals
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced that its registration statement on Form S-4 in connection with the proposed merger with Notable Labs, Inc. (“Notable”) has been declared effective by the U.S. Securities and Exchange Commission (“SEC”).
September 6, 2023
·
8 min read
Business
VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
VBL Therapeutics, announced financial results for the first quarter ended March 31, 2023, and provided a corporate update.
May 15, 2023
·
9 min read
Business
VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
VBL Therapeutics (Nasdaq: VBLT) (VBL), today announced financial results for the fiscal year ended December 31, 2022, and provided a corporate update.
March 14, 2023
·
10 min read
Deals
VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
VBL Therapeutics (Nasdaq:VBLT), a biotechnology company developing targeted medicines for immune-inflammatory diseases, and Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced they have entered into a definitive merger agreement.
February 23, 2023
·
14 min read
Deals
Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, announced that it has acquired a manufacturing facility in Modi’in, Israel, and certain related assets from biotechnology company VBL Therapeutics.
March 1, 2023
·
4 min read
Pharm Country
VBL Therapeutics Announces Closing of Sale of Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash
VBL Therapeutics announced that it has closed on the previously announced sale of its manufacturing facility in Modi’in, Israel, and certain related assets, for $7.1 million in cash to Aleph Farms, an Israel-based food technology company.
March 9, 2023
·
5 min read
1 of 25,601
Next